Patent · US Active

Methods for treating retinopathy with extended therapeutic effect

US8911768B2 · kind B2 · utility

62Cited by
106References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 17, 2014
Grant dateDec 16, 2014
Priority date
Expiry dateJun 17, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K16/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for treating and preventing retinopathic conditions by administering an anti-VEGF compound to the vitreous chamber of a patient at risk of, or suffering from, the retinopathy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.